
This series explores the evolving role of immunotherapy in earlier stages of bladder cancer, highlighting key clinical trials that evaluate combination strategies in both muscle-invasive and non–muscle invasive disease.

This series explores the evolving role of immunotherapy in earlier stages of bladder cancer, highlighting key clinical trials that evaluate combination strategies in both muscle-invasive and non–muscle invasive disease.

This series explores the evolving immunotherapy treatment landscape across all stages of bladder cancer, including non-muscle-invasive, muscle-invasive, and metastatic.


In this series, experts discuss best practices for clinical use of onabotulinumtoxinA in the managements of overactive bladder.

This series showcases an ongoing clinical trial of detalimogene voraplasmid and highlights the evolving treatment landscape of non–muscle invasive bladder cancer.

Neal Shore, MD, FACS and Rana McKay, MD discuss recent advances in understanding and targeting androgen receptor signaling in metastatic prostate cancer and emerging treatment approaches.

This digital series features articles and videos with insights and expert viewpoints on PSMA-PET and the evolving imaging paradigm that is revolutionizing the diagnosis and treatment of patients with prostate cancer.

This digital series comprised of videos and articles led by experts in the field examines the evolving role of novel imaging modalities in the identification and management of patients with prostate cancer.

This digital series explores the challenges and unmet needs in the management of advanced/metastatic prostate cancer with focus on the use of leuprolide, and the clinical and financial factors physicians consider when recommending leuprolide as a treatment option.

This series comprised of videos and articles features experts on prostate cancer sharing clinical insights on the role of micronized abiraterone.

This series comprised of videos and articles explores the role of perirectal spacers and the multidisciplinary approach to treating patients with prostate cancer.

This digital series examines challenges and unmet needs in the management of advanced/metastatic prostate cancer with emphasis on leuprolide treatment and understanding the interplay among clinical, economic, and organizational management perspectives that physicians consider when prescribing leuprolide.

This digital series explores challenges and unmet needs in the treatment of low-grade upper tract urothelial carcinoma (LG-UTUC) and reviews key advancements in the therapeutic landscape with emphasis on emerging precision medicine-based approaches.